Gilead Sciences
GILD
#121
Rank
C$230.54 B
Marketcap
C$185.69
Share price
2.96%
Change (1 day)
27.53%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.50

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.47. In 2024 the company made an earnings per share (EPS) of C$0.53 a decrease over its 2023 EPS that were of C$6.29.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.501708.38%
2024C$0.53-91.65%
2023C$6.2923.98%
2022C$5.07-25.86%
2021C$6.844850%
2020C$0.14-97.64%
2019C$5.860.9%
2018C$5.8118.71%
2017C$4.89-64.88%
2016C$13.93-18.45%
2015C$17.0855.28%
2014C$11.00296.02%
2013C$2.7817.89%
2012C$2.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.07 27.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.81-80.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.84-69.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.01 312.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.01 111.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$12.92 36.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.64-19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$23.51 148.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$4.92-48.07%๐Ÿ‡บ๐Ÿ‡ธ USA